Wall Street Backs the Wrong Biotech

In this video, David Williamson reviews some of his favorite biotech firms. Many analysts have thrown their weight behind Biogen  (NASDAQ: BIIB  ) and its new BG12 drug for multiple sclerosis. However, David favors Gilead  (NASDAQ: GILD  ) over Biogen since Gilead has a larger, more diverse product pipeline. Celgene  (NASDAQ: CELG  ) is the No. 1 biotech in David's opinion since it also has blockbuster drugs but a PEG of less than 1.0. Amgen  (NASDAQ: AMGN  ) is a big company with more products in development than most people realize. Overall, for value and future earnings potential, David likes Celgene the best.

Can Celgene continue to soar?
Every in-the-know biotech investor has an eye on Celgene. Shares have skyrocketed this year as the company outlined a plan to almost triple its profits in only a few years. But should you buy the story Celgene is selling? Make sure you understand the key opportunities and risks facing this company by picking up The Motley Fool's brand-new premium report on Celgene. To claim your copy today, simply click here now.


Read/Post Comments (3) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 14, 2013, at 4:38 PM, RU1986 wrote:

    Spelling Biogen's name correctly might get your opinion a little more consideration.

  • Report this Comment On April 15, 2013, at 8:30 AM, Grayhouse wrote:

    Seriously! Who's the really the "fool"? Anyone that listens to your short backed speech disguised as analysis.

  • Report this Comment On April 15, 2013, at 9:59 AM, XMFSharona wrote:

    @RU1986 & @Grayhouse -- Thanks for the feedback; we've made the fix. Fool on!

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2361982, ~/Articles/ArticleHandler.aspx, 12/22/2014 6:31:43 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement